| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human Colon: right; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIES | CS808429 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Colon: right; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIES | CS809632 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Colon: right; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIES | CS809633 | 5x5um | ORIGENE TECHNOLOGIES |
| CD28 molecule (CD28) from ORIGENE TECHNOLOGIES | LY401849 | 100 ug | ORIGENE TECHNOLOGIES |
| CD302 molecule (CD302) from ORIGENE TECHNOLOGIES | LY402391 | 100 ug | ORIGENE TECHNOLOGIES |
| CD38 molecule (CD38) from ORIGENE TECHNOLOGIES | LY419752 | 100 ug | ORIGENE TECHNOLOGIES |
| CD4 molecule (CD4) from ORIGENE TECHNOLOGIES | LY400209 | 100 ug | ORIGENE TECHNOLOGIES |
| CD48 molecule (CD48) from ORIGENE TECHNOLOGIES | LY419755 | 100 ug | ORIGENE TECHNOLOGIES |
| CD5 molecule (CD5) from ORIGENE TECHNOLOGIES | LY415443 | 100 ug | ORIGENE TECHNOLOGIES |
| CD52 molecule (CD52) from ORIGENE TECHNOLOGIES | LY419739 | 100 ug | ORIGENE TECHNOLOGIES |
| CD7 molecule (CD7) from ORIGENE TECHNOLOGIES | LY416844 | 100 ug | ORIGENE TECHNOLOGIES |
| CD70 molecule (CD70) from ORIGENE TECHNOLOGIES | LY400501 | 100 ug | ORIGENE TECHNOLOGIES |
| CD72 molecule (CD72) from ORIGENE TECHNOLOGIES | LY400673 | 100 ug | ORIGENE TECHNOLOGIES |
| CD81 molecule (CD81) from ORIGENE TECHNOLOGIES | LY418041 | 100 ug | ORIGENE TECHNOLOGIES |
| CD84 molecule (CD84) from ORIGENE TECHNOLOGIES | LY401277 | 100 ug | ORIGENE TECHNOLOGIES |
| CD9 molecule (CD9) from ORIGENE TECHNOLOGIES | LY400677 | 100 ug | ORIGENE TECHNOLOGIES |
| CD93 molecule (CD93) from ORIGENE TECHNOLOGIES | LY415997 | 100 ug | ORIGENE TECHNOLOGIES |
| CD14 molecule (CD14), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424624 | 100 ug | ORIGENE TECHNOLOGIES |
| CD14 molecule (CD14), transcript variant 2 from ORIGENE TECHNOLOGIES | LY421877 | 100 ug | ORIGENE TECHNOLOGIES |
| CD163 molecule (CD163), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401362 | 100 ug | ORIGENE TECHNOLOGIES |
| CD200 molecule (CD200), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401799 | 100 ug | ORIGENE TECHNOLOGIES |
| CD200 molecule (CD200), transcript variant 2 from ORIGENE TECHNOLOGIES | LY424074 | 100 ug | ORIGENE TECHNOLOGIES |
| CD200 molecule (CD200), transcript variant 2 from ORIGENE TECHNOLOGIES | LY425122 | 100 ug | ORIGENE TECHNOLOGIES |
| CD209 molecule (CD209), transcript variant 1 from ORIGENE TECHNOLOGIES | LY402847 | 100 ug | ORIGENE TECHNOLOGIES |
| CD22 molecule (CD22), transcript variant 4 from ORIGENE TECHNOLOGIES | LY434364 | 100 ug | ORIGENE TECHNOLOGIES |
| CD247 molecule (CD247), transcript variant 1 from ORIGENE TECHNOLOGIES | LY403667 | 100 ug | ORIGENE TECHNOLOGIES |
| CD247 molecule (CD247), transcript variant 2 from ORIGENE TECHNOLOGIES | LY424538 | 100 ug | ORIGENE TECHNOLOGIES |
| CD276 molecule (CD276), transcript variant 1 from ORIGENE TECHNOLOGIES | LY425464 | 100 ug | ORIGENE TECHNOLOGIES |
| CD84 molecule (CD84), transcript variant 1 from ORIGENE TECHNOLOGIES | LY432917 | 100 ug | ORIGENE TECHNOLOGIES |
| CD84 molecule (CD84), transcript variant 3 from ORIGENE TECHNOLOGIES | LY432804 | 100 ug | ORIGENE TECHNOLOGIES |
| CD96 molecule (CD96), transcript variant 2 from ORIGENE TECHNOLOGIES | LY417050 | 100 ug | ORIGENE TECHNOLOGIES |
| CD97 molecule (CD97), transcript variant 1 from ORIGENE TECHNOLOGIES | LY409190 | 100 ug | ORIGENE TECHNOLOGIES |
| CD97 molecule (CD97), transcript variant 2 from ORIGENE TECHNOLOGIES | LY400675 | 100 ug | ORIGENE TECHNOLOGIES |
| CD99 molecule (CD99), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400863 | 100 ug | ORIGENE TECHNOLOGIES |
| CD99 molecule (CD99), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426583 | 100 ug | ORIGENE TECHNOLOGIES |
| CD59 molecule, complement regulatory protein (CD59), transcript variant 1 from ORIGENE TECHNOLOGIES | LY404398 | 100 ug | ORIGENE TECHNOLOGIES |
| CD59 molecule, complement regulatory protein (CD59), transcript variant 1 from ORIGENE TECHNOLOGIES | LY430909 | 100 ug | ORIGENE TECHNOLOGIES |
| CD59 molecule, complement regulatory protein (CD59), transcript variant 2 from ORIGENE TECHNOLOGIES | LY424608 | 100 ug | ORIGENE TECHNOLOGIES |
| CD59 molecule, complement regulatory protein (CD59), transcript variant 3 from ORIGENE TECHNOLOGIES | LY404397 | 100 ug | ORIGENE TECHNOLOGIES |
| CD59 molecule, complement regulatory protein (CD59), transcript variant 3 from ORIGENE TECHNOLOGIES | LY430908 | 100 ug | ORIGENE TECHNOLOGIES |
| CD59 molecule, complement regulatory protein (CD59), transcript variant 4 from ORIGENE TECHNOLOGIES | LY430910 | 100 ug | ORIGENE TECHNOLOGIES |
| CD59 molecule, complement regulatory protein (CD59), transcript variant 4 from ORIGENE TECHNOLOGIES | LY404399 | 100 ug | ORIGENE TECHNOLOGIES |
| CD59 molecule, complement regulatory protein (CD59), transcript variant 5 from ORIGENE TECHNOLOGIES | LY426723 | 100 ug | ORIGENE TECHNOLOGIES |
| CD59 molecule, complement regulatory protein (CD59), transcript variant 6 from ORIGENE TECHNOLOGIES | LY426724 | 100 ug | ORIGENE TECHNOLOGIES |
| CD59 molecule, complement regulatory protein (CD59), transcript variant 7 from ORIGENE TECHNOLOGIES | LY426725 | 100 ug | ORIGENE TECHNOLOGIES |
| CD59 molecule, complement regulatory protein (CD59), transcript variant 8 from ORIGENE TECHNOLOGIES | LY426726 | 100 ug | ORIGENE TECHNOLOGIES |
| CD46 molecule, complement regulatory protein (CD46), transcript variant n from ORIGENE TECHNOLOGIES | LY406718 | 100 ug | ORIGENE TECHNOLOGIES |
| CD55 molecule, decay accelerating factor for complement (Cromer blood group) (CD55), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424635 | 100 ug | ORIGENE TECHNOLOGIES |
| CD55 molecule, decay accelerating factor for complement (Cromer blood group) (CD55), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426508 | 100 ug | ORIGENE TECHNOLOGIES |
| CD248 molecule, endosialin (CD248) from ORIGENE TECHNOLOGIES | LY412436 | 100 ug | ORIGENE TECHNOLOGIES |